{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:29:45Z","timestamp":1772062185294,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Paraneoplastic pityriasis rubra pilaris (PRP) is a rare and poorly defined chronic inflammatory skin condition. Recognition of its potential association with cancer is crucial to facilitate timely diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To summarize published literature on paraneoplastic PRP, with a focus on associated cancer types, latency periods, treatment outcomes and resolution following oncological management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature review was conducted following PRISMA guidelines using the MEDLINE, Embase, Cochrane Library and Web of Science databases. Search terms used were \u2018pityriasis rubra pilaris\u2019, \u2018malignancy\u2019, \u2018cancer\u2019 and \u2018paraneoplastic\u2019, and inclusion criteria were adults diagnosed with both cancer and probable paraneoplastic PRP. Two authors independently reviewed the titles and abstracts of all identified papers before the full text of potentially relevant studies was retrieved for further analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 978 articles screened, 22 studies describing 23 adult patients were included. Solid tumours were implicated in 83% of cases (n = 19\/23), with lung cancer the most common of these (n = 7\/19, 37%). The median latency from PRP onset to cancer diagnosis was 9 weeks [interquartile range (IQR): 0.4\u201325.0]. Among 17 patients experiencing complete or partial resolution of PRP following treatment for their cancer, complete resolution occurred in 65% (n = 11\/17), typically within a median of 11 weeks (IQR: 6.8\u201322.8). The overall mortality rate in evaluable cases was 16% (n = 3\/19).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this systematic review, paraneoplastic PRP was associated with multiple types of cancer, both solid and haematological. Cancer screening should be considered in cases of atypical or treatment-refractory PRP. Further prospective studies are required to define predictive features and optimize diagnostic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llaf472","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:21:58Z","timestamp":1761222118000},"page":"374-380","source":"Crossref","is-referenced-by-count":1,"title":["Paraneoplastic pityriasis rubra pilaris: a systematic review"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3798-0279","authenticated-orcid":false,"given":"James","family":"Gaston","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Royal Children\u2019s Hospital Melbourne , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9877-1730","authenticated-orcid":false,"given":"Andrew","family":"Maxwell","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Melbourne Hospital , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3976-1432","authenticated-orcid":false,"given":"Francis Yi Xing","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Monash Health , Clayton, VIC ,","place":["Australia"]},{"name":"Skin Health Institute , Carlton, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0246-0484","authenticated-orcid":false,"given":"Senhong","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Monash Health , Clayton, VIC ,","place":["Australia"]},{"name":"Skin Health Institute , Carlton, VIC ,","place":["Australia"]},{"name":"Department of Dermatology, Eastern Health , Box Hill, VIC ,","place":["Australia"]},{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University , Clayton, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"2026022406173641600_llaf472-B1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40257-017-0338-1","article-title":"A review on pityriasis rubra pilaris","volume":"19","author":"Wang","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"2026022406173641600_llaf472-B2","first-page":"243","article-title":"Systemic therapies of pityriasis rubra pilaris: a systematic review","volume":"17","author":"Kromer","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"2026022406173641600_llaf472-B3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/12034754231223159","article-title":"Updates on pityriasis rubra pilaris: a scoping review","volume":"28","author":"Zhou","year":"2024","journal-title":"J Cutan Med Surg"},{"key":"2026022406173641600_llaf472-B4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jdcr.2022.12.007","article-title":"Rethinking pityriasis rubra pilaris as a paraneoplastic syndrome: two cases of pityriasis rubra pilaris with concomitant underlying malignancy","volume":"32","author":"Davis","year":"2022","journal-title":"JAAD Case Rep"},{"key":"2026022406173641600_llaf472-B5","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026022406173641600_llaf472-B6","author":"Joanna Briggs Institute"},{"key":"2026022406173641600_llaf472-B7","author":"Oxford Centre for Evidence-Based Medicine. OCEBM levels of evidence"},{"key":"2026022406173641600_llaf472-B8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ced.13009","article-title":"Paraneoplastic pityriasis rubra pilaris: case report and literature review","volume":"42","author":"Bar-Ilan","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"2026022406173641600_llaf472-B9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2230.2005.01781.x","article-title":"Pityriasis rubra pilaris as the initial presentation of renal cell carcinoma?","volume":"30","author":"Batchelor","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"2026022406173641600_llaf472-B10","doi-asserted-by":"crossref","first-page":"e917","DOI":"10.1111\/j.1365-2230.2009.03701.x","article-title":"Pityriasis rubra pilaris in association with laryngeal carcinoma","volume":"34","author":"Batinac","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"2026022406173641600_llaf472-B11","first-page":"701","article-title":"Paraneoplastic erythroderma: a case associated to esophagus carcinoma.","volume":"87","author":"Casta\u00f1o Suarez","year":"1996","journal-title":"Actas Dermosifiliogr"},{"key":"2026022406173641600_llaf472-B12","first-page":"5052","article-title":"Paraneoplastic pityriasis rubra pilaris in association with prostate carcinoma: a case report and literature review","volume":"18","author":"Fekete","year":"2019","journal-title":"Exp Ther Med"},{"issue":"2S2","key":"2026022406173641600_llaf472-B13","first-page":"526","article-title":"Paradoxical cutaneous reactions to anti TNF-alpha in paediatric patients with inflammatory bowel disease: experience in our unit","volume":"74","author":"Garcia","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2026022406173641600_llaf472-B14","first-page":"7","article-title":"Pityriasis rubra pilaris. Something more than a disorder of queratinization?","volume":"46","author":"Garc\u00eda-Briz","year":"","journal-title":"Med Cutan Iber Lat Am 2018"},{"key":"2026022406173641600_llaf472-B15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5070\/D36VR5R017","article-title":"Letter: Adenocarcinoma of the lung associated with pityriasis rubra pilaris","volume":"17","author":"Garretson","year":"2011","journal-title":"Dermatol Online J"},{"key":"2026022406173641600_llaf472-B16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2002-20423","article-title":"Paraneoplastic pityriasis rubra pilaris in metastatic adenocarcinoma without diagnosable primary","volume":"127","author":"Kloos","year":"2002","journal-title":"Dtsch Med Wochenschr"},{"key":"2026022406173641600_llaf472-B17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ajh.25897","article-title":"Paraneoplastic pityriasis rubra pilaris heralding onset of new hematologic malignancy","volume":"96","author":"Kwak","year":"2021","journal-title":"Am J Hematol"},{"key":"2026022406173641600_llaf472-B18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1440-0960.2004.00061.x","article-title":"Paraneoplastic pityriasis rubra pilaris in association with bronchogenic carcinoma","volume":"45","author":"Kurzydlo","year":"2004","journal-title":"Australas J Dermatol"},{"key":"2026022406173641600_llaf472-B19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdcr.2021.04.025","article-title":"A case of recurrent and paraneoplastic pityriasis rubra pilaris","volume":"12","author":"Lamberg","year":"2021","journal-title":"JAAD Case Rep"},{"key":"2026022406173641600_llaf472-B20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/qjmed\/hcae192","article-title":"Pityriasis rubra pilaris and underlying malignancy","volume":"118","author":"Lin","year":"2025","journal-title":"QJM"},{"key":"2026022406173641600_llaf472-B21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jdcr.2023.06.045","article-title":"A case of paraneoplastic pityriasis rubra pilaris","volume":"39","author":"Mehta","year":"2023","journal-title":"JAAD Case Rep"},{"key":"2026022406173641600_llaf472-B22","first-page":"100","article-title":"Pityriasis rubra pilaris as the initial manifestation of leukemia","volume":"31","author":"Reinhardt","year":"1983","journal-title":"Cutis"},{"key":"2026022406173641600_llaf472-B23","first-page":"610","article-title":"Paraneoplastic pityriasis rubra pilaris as the presenting manifestation of metastatic squamous cell carcinoma","volume":"13","author":"Remedios","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"2026022406173641600_llaf472-B24","first-page":"1046","article-title":"Pityriasis rubra pilaris the precursor of a Sezary\u2019s syndrome.","volume":"66","author":"Roger","year":"1992","journal-title":"H&G Zeitschrift fur Hautkrankheiten"},{"key":"2026022406173641600_llaf472-B25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000246088","article-title":"Pityriasis rubra pilaris as an initial presentation of hepatocellular carcinoma","volume":"194","author":"Sharma","year":"1997","journal-title":"Dermatology"},{"key":"2026022406173641600_llaf472-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASW.0000826828.53117.8c","article-title":"Paraneoplastic pityriasis rubra pilaris preceding leukemia","volume":"35","author":"Vance","year":"2022","journal-title":"Adv Skin Wound Care"},{"key":"2026022406173641600_llaf472-B27","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.jaad.2010.05.013","article-title":"Pityriasis rubra pilaris: was it the first manifestation of colon cancer in a patient with pre-existing psoriasis?","volume":"68","author":"Vitiello","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2026022406173641600_llaf472-B28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D328458518","article-title":"Pityriasis rubra pilaris heralding diagnosis of urothelial carcinoma: a case report","volume":"28","author":"Young","year":"2022","journal-title":"Dermatol Online J"},{"key":"2026022406173641600_llaf472-B29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2230.1995.tb01368.x","article-title":"Pityriasis rubra pilaris as the initial manifestation of internal neoplasia","volume":"20","author":"S\u00e1nchez-Rega\u00f1a","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"2026022406173641600_llaf472-B30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.clindermatol.2019.07.030","article-title":"Pityriasis rubra pilaris as a systemic disease","volume":"37","author":"Kamarachev","year":"2019","journal-title":"Clin Dermatol"},{"key":"2026022406173641600_llaf472-B31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jid.2021.06.009","article-title":"Pityriasis rubra pilaris response to IL-17A inhibition is associated with IL-17C and CCL20 protein levels","volume":"142","author":"Strunck","year":"2022","journal-title":"J Invest Dermatol"},{"key":"2026022406173641600_llaf472-B32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0365-05962013000100001","article-title":"Paraneoplastic cutaneous manifestations: concepts and updates","volume":"88","author":"da Silva","year":"2013","journal-title":"An Bras Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf472\/64925337\/llaf472.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/3\/374\/64925337\/llaf472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/3\/374\/64925337\/llaf472.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:17:49Z","timestamp":1771931869000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/3\/374\/8301031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,10,24]]},"published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf472","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,10,24]]}}}